RIP II Toxin Detection via 28S rRNA Depurination and cDNA Ligation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting ricin intoxication, particularly for RIP II toxins, are not suitable for identifying minute amounts of the toxin in clinical samples, limiting their effectiveness for early detection and diagnosis.

Innovation Solution

A method involving reverse transcriptase-driven primer extension, followed by labeling and PCR amplification of truncated cDNA transcripts, specifically targets depurination sites in 28S rRNA to detect exposure to RIP II family toxins, enhancing sensitivity through the use of synthetic nucleic acid ligation and quantitative real-time PCR.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional detection methods are used, then the detection process is simple, but the detection sensitivity is insufficient for minute amounts of toxin

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The detection method is divided into distinct sequential steps: reverse transcription of 28S rRNA to cDNA, ligation of synthetic DNA strand to the cDNA, and PCR amplification. This segmentation allows each step to be optimized independently, with the ligation step specifically targeting the depurination site to enhance detection sensitivity for minute toxin amounts.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A synthetic DNA strand serves as an intermediary molecule that ligates to the reverse-transcribed cDNA at the depurination site. This intermediary enables specific labeling and amplification of the toxin-damaged RNA, significantly enhancing detection sensitivity while maintaining a manageable procedural complexity through standardized molecular biology techniques.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional detection methods are used, then the procedure is straightforward, but the detection limit is too high for clinical diagnosis

Engineering Contradiction:
Improvedetection limitVSAvoidprocedure complexity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The method performs preliminary reverse transcription of the 28S rRNA to cDNA and ligation of the synthetic DNA strand before PCR amplification. This preliminary action concentrates the detection signal at the specific depurination site, enabling detection of minute toxin amounts (pg/ml level) while using standard, well-established molecular biology techniques that remain relatively easy to operate.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method changes the physical-chemical parameters of the detection system by converting RNA to cDNA and introducing a synthetic DNA strand with specific sequences for PCR amplification. These parameter changes enable detection at pg/ml concentration levels while maintaining ease of operation through conventional PCR technology.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If sensitive detection methods are developed, then the detection sensitivity improves, but the method complexity increases

Engineering Contradiction:
Improvetoxin detection sensitivityVSAvoidassay procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The synthetic DNA strand serves multiple functions: it ligates to the reverse-transcribed cDNA at the depurination site, provides a unique sequence for specific PCR amplification, and enables detection of the toxin's catalytic activity. This multi-functionality achieves high detection sensitivity while avoiding the need for multiple separate assays, thereby controlling overall procedural complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The method replaces direct toxin detection with an indirect molecular biology approach: toxin-catalyzed depurination is converted to RNA-to-cDNA reverse transcription, then to ligated chimeric DNA, and finally to amplified PCR products. This substitution of mechanical/direct detection with biochemical amplification steps dramatically enhances sensitivity while using standardized, well-characterized molecular techniques.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the detection of ricin at concentrations as low as 5 pg/ml, significantly improving the sensitivity and accuracy of ricin detection in clinical samples, enabling early identification of exposure and ribosomal damage.

Implementation Method 1

Performing a reverse transcriptase (RT) reaction using a primer complementary to a sequence of the 28S rRNA

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 2

Labeling said truncated cDNA transcript obtained in step (b) by ligating a synthetic nucleic acid (e.g. DNA) strand at the truncated 3' end of the transcript

Methodology Applied
Scientific EffectLigation:

Implementation Method 3

Amplifying the chimeric ligation product using polymerase chain reaction (PCR)

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 4

The RNA-N-glycosidase activity of the RIP toxins causes depurination of a specific nucleotide in the 28S-rRNA at the position corresponding to A 4324

Methodology Applied
Scientific EffectDepurination: Hydrolysis

Data Source

PatentEP3401408B1Detection of exposure to rip ii toxins
Publication Date: 2019.11.20 THE ISRAEL INST OF BIOLOGICAL RES IIBR
  • EP3401408B1 patent drawingFigure 1A~1B
  • EP3401408B1 patent drawingFigure 1C~1D
  • EP3401408B1 patent drawingFigure 2A

AI summary

The present invention relates to methods and kits for the detection of intoxication with a RIP II toxin, in particular ricin intoxication of human subjects by detecting depurination of 28S rRNA by a method which involves reverse transcription, optionally using a thermostable RT enzyme, ligation and PCR.